SCN8A
Sodium channel protein type 8 subunit alpha
Also known as: CerIII, CIAT, MED, NaCh6, Nav1.6, PN4, SCN8A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UQD0
- Gene
- SCN8A
- Ensembl
- ENSG00000196876
- Chromosome
- 12
- Canonical length
- 1980 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Subcellular location
- Vesicles,Plasma membrane,Cell Junctions
OverviewNCBI Gene
This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
1980 residues, UniProt reviewed canonical sequence.
>Q9UQD0|SCN8A
1 MAARLLAPPG PDSFKPFTPE SLANIERRIA ESKLKKPPKA DGSHREDDED SKPKPNSDLE
61 AGKSLPFIYG DIPQGLVAVP LEDFDPYYLT QKTFVVLNRG KTLFRFSATP ALYILSPFNL
121 IRRIAIKILI HSVFSMIIMC TILTNCVFMT FSNPPDWSKN VEYTFTGIYT FESLVKIIAR
181 GFCIDGFTFL RDPWNWLDFS VIMMAYITEF VNLGNVSALR TFRVLRALKT ISVIPGLKTI
241 VGALIQSVKK LSDVMILTVF CLSVFALIGL QLFMGNLRNK CVVWPINFNE SYLENGTKGF
301 DWEEYINNKT NFYTVPGMLE PLLCGNSSDA GQCPEGYQCM KAGRNPNYGY TSFDTFSWAF
361 LALFRLMTQD YWENLYQLTL RAAGKTYMIF FVLVIFVGSF YLVNLILAVV AMAYEEQNQA
421 TLEEAEQKEA EFKAMLEQLK KQQEEAQAAA MATSAGTVSE DAIEEEGEEG GGSPRSSSEI
481 SKLSSKSAKE RRNRRKKRKQ KELSEGEEKG DPEKVFKSES EDGMRRKAFR LPDNRIGRKF
541 SIMNQSLLSI PGSPFLSRHN SKSSIFSFRG PGRFRDPGSE NEFADDEHST VEESEGRRDS
601 LFIPIRARER RSSYSGYSGY SQGSRSSRIF PSLRRSVKRN STVDCNGVVS LIGGPGSHIG
661 GRLLPEATTE VEIKKKGPGS LLVSMDQLAS YGRKDRINSI MSVVTNTLVE ELEESQRKCP
721 PCWYKFANTF LIWECHPYWI KLKEIVNLIV MDPFVDLAIT ICIVLNTLFM AMEHHPMTPQ
781 FEHVLAVGNL VFTGIFTAEM FLKLIAMDPY YYFQEGWNIF DGFIVSLSLM ELSLADVEGL
841 SVLRSFRLLR VFKLAKSWPT LNMLIKIIGN SVGALGNLTL VLAIIVFIFA VVGMQLFGKS
901 YKECVCKINQ DCELPRWHMH DFFHSFLIVF RVLCGEWIET MWDCMEVAGQ AMCLIVFMMV
961 MVIGNLVVLN LFLALLLSSF SADNLAATDD DGEMNNLQIS VIRIKKGVAW TKLKVHAFMQ
1021 AHFKQREADE VKPLDELYEK KANCIANHTG ADIHRNGDFQ KNGNGTTSGI GSSVEKYIID
1081 EDHMSFINNP NLTVRVPIAV GESDFENLNT EDVSSESDPE GSKDKLDDTS SSEGSTIDIK
1141 PEVEEVPVEQ PEEYLDPDAC FTEGCVQRFK CCQVNIEEGL GKSWWILRKT CFLIVEHNWF
1201 ETFIIFMILL SSGALAFEDI YIEQRKTIRT ILEYADKVFT YIFILEMLLK WTAYGFVKFF
1261 TNAWCWLDFL IVAVSLVSLI ANALGYSELG AIKSLRTLRA LRPLRALSRF EGMRVVVNAL
1321 VGAIPSIMNV LLVCLIFWLI FSIMGVNLFA GKYHYCFNET SEIRFEIEDV NNKTECEKLM
1381 EGNNTEIRWK NVKINFDNVG AGYLALLQVA TFKGWMDIMY AAVDSRKPDE QPKYEDNIYM
1441 YIYFVIFIIF GSFFTLNLFI GVIIDNFNQQ KKKFGGQDIF MTEEQKKYYN AMKKLGSKKP
1501 QKPIPRPLNK IQGIVFDFVT QQAFDIVIMM LICLNMVTMM VETDTQSKQM ENILYWINLV
1561 FVIFFTCECV LKMFALRHYY FTIGWNIFDF VVVILSIVGM FLADIIEKYF VSPTLFRVIR
1621 LARIGRILRL IKGAKGIRTL LFALMMSLPA LFNIGLLLFL VMFIFSIFGM SNFAYVKHEA
1681 GIDDMFNFET FGNSMICLFQ ITTSAGWDGL LLPILNRPPD CSLDKEHPGS GFKGDCGNPS
1741 VGIFFFVSYI IISFLIVVNM YIAIILENFS VATEESADPL SEDDFETFYE IWEKFDPDAT
1801 QFIEYCKLAD FADALEHPLR VPKPNTIELI AMDLPMVSGD RIHCLDILFA FTKRVLGDSG
1861 ELDILRQQME ERFVASNPSK VSYEPITTTL RRKQEEVSAV VLQRAYRGHL ARRGFICKKT
1921 TSNKLENGGT HREKKESTPS TASLPSYDSV TKPEKEKQQR AEEGRRERAK RQKEVRESKCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SCN8A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 24
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 17 nTPM
- cerebral cortex: 16 nTPM
- hippocampal formation: 8.9 nTPM
- retina: 7.3 nTPM
- basal ganglia: 7 nTPM
- pituitary gland: 6.3 nTPM
Single-cell type
- brain excitatory neurons: 367 nCPM
- brain inhibitory neurons: 321 nCPM
- thyrotrophs: 256 nCPM
- gonadotrophs: 256 nCPM
- somatotrophs: 251 nCPM
- lactotrophs: 246 nCPM
Immune cell
- basophil: 0.4 nTPM
- neutrophil: 0.4 nTPM
- eosinophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- cerebral cortex: 130 nTPM
- white matter: 79 nTPM
- hippocampal formation: 78 nTPM
- pons: 61 nTPM
- basal ganglia: 60 nTPM
- medulla oblongata: 55 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SCN8A.
Disease | AllUniProt
Conditions SCN8A is implicated in, by any mechanism.
- Cognitive impairment with or without cerebellar ataxia (CIAT) MIM:614306
- Developmental and epileptic encephalopathy 13 (DEE13) MIM:614558
- Seizures, benign familial infantile, 5 (BFIS5) MIM:617080
- Myoclonus, familial, 2 (MYOCL2) MIM:618364
Disease | GeneticClinVar
373 pathogenic / likely-pathogenic of 2,545 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Early-infantile DEE
- Developmental and epileptic encephalopathy, 13
- Cognitive impairment with or without cerebellar ataxia
- Complex neurodevelopmental disorder
- Seizures, benign familial infantile, 5
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 7.64
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- action potential
- cardiac muscle cell action potential involved in contraction
- myelination
- peripheral nervous system development
- sodium ion transmembrane transport
- sodium ion transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- IQ motif, EF-hand binding site
- Voltage gated sodium channel, alpha subunit
- Ion transport domain
- Sodium ion transport-associated domain
- Voltage-gated Na+ ion channel, cytoplasmic domain
- Voltage-dependent channel domain superfamily
- Voltage-gated cation channel calcium and sodium
- Voltage-gated sodium channel alpha subunit, inactivation gate
- SCN5A-like, C-terminal IQ motif
- Ion transport protein
- Sodium ion transport-associated
- Cytoplasmic domain of voltage-gated Na+ ion channel
- SCN5A-like, C-terminal IQ motif
- Voltage gated sodium channel, alpha-8 subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SCN8A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SCN8A as an antibody target. Whether an autoantibody or antibody against SCN8A could matter depends on whether native SCN8A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SCN8A is annotated at the cell surface, where native SCN8A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SCN8A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...